Atlas Trials

CAR-NK Targeted CD19 for r/r B-cell Malignancies

Clinical trial NCT05645601 · UNKNOWN

Trial details

NCT number
NCT05645601
Sponsor
Affiliated Hospital to Academy of Military Medical Sciences
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Relapsed/Refractory B-cell Hematologic Malignancies
Start date
2022-12-01
Primary completion
2024-05-30
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.